MarketPeel
Insider Trading Intelligence
Pricing
…
KG

Kathleen Goin

PVLA
CHIEF OPERATING OFFICER · PALVELLA THERAPEUTICS, INC. · CIK 0001912570
FILING MIX · LIFETIME35%/65%
BUYS
20
SELLS
37
TOTAL VALUE
$3.83M
COMPANIES
1
ACTIVE SINCE
Dec 2024
HOLDINGS NOW
2,154
AVG SELL PX
$103.28
TRADE KIND
SHOWING 57 / 57
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons · 47 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Kathleen Goin, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+13.33%+9.07%+1.26%+7.82%+0.60%—
14d15+60.00%+7.37%+0.89%+6.48%-6.47%—
30d15+46.67%+5.84%+3.40%+2.45%+0.20%—
60d15+40.00%+5.92%+4.97%+0.94%-7.07%—
90d15(5 pending)+50.00%+15.00%+7.01%+7.99%+5.49%—
180d15(12 pending)+0.00%+20.35%+11.51%+8.84%+11.93%—
1y15(15 pending)——————
2y15(15 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PVLA · 2,154 shares · as of Jun 17, 2026
030,89061,78092,669123,55920252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2024
2025
2025
2025
2025
2026
2026
FLOW · 20 buys / 37 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,154$7.14$15.4K2,154Jun 17, 2026Jun 22, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,390$110.26$263.5K1,912Jun 17, 2026Jun 22, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
25$112.23$2.8K0Jun 17, 2026Jun 22, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,148——8,592Jun 17, 2026Jun 22, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,148$9.08$19.5K4,302Jun 17, 2026Jun 22, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,887$111.31$210.0K25Jun 17, 2026Jun 22, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,154——8,627Jun 17, 2026Jun 22, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
48$111.90$5.4K0May 20, 2026May 22, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,363$110.35$371.1K939May 20, 2026May 22, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,148——10,740May 20, 2026May 22, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,154$7.14$15.4K2,154May 20, 2026May 22, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,148$9.08$19.5K4,302May 20, 2026May 22, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,154——10,781May 20, 2026May 22, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
891$111.30$99.2K48May 20, 2026May 22, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,154$7.14$15.4K2,154Apr 15, 2026Apr 17, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,148——12,888Apr 15, 2026Apr 17, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,502$125.96$189.2K2,800Apr 15, 2026Apr 17, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
561$128.23$71.9K739Apr 15, 2026Apr 17, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,154——12,935Apr 15, 2026Apr 17, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,500$127.13$190.7K1,300Apr 15, 2026Apr 17, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
639$129.17$82.5K100Apr 15, 2026Apr 17, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
100$130.33$13.0K0Apr 15, 2026Apr 17, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,148$9.08$19.5K4,302Apr 15, 2026Apr 17, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,154$7.14$15.4K2,154Mar 18, 2026Mar 20, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,268$117.56$266.6K2,034Mar 18, 2026Mar 20, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,730$118.37$204.8K304Mar 18, 2026Mar 20, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,148——15,036Mar 18, 2026Mar 20, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,148$9.08$19.5K4,302Mar 18, 2026Mar 20, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,154——15,089Mar 18, 2026Mar 20, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
304$119.08$36.2K0Mar 18, 2026Mar 20, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,154——17,243Feb 18, 2026Feb 20, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,148$9.08$19.5K4,302Feb 18, 2026Feb 20, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,154$7.14$15.4K2,154Feb 18, 2026Feb 20, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,276$79.97$102.0K0Feb 18, 2026Feb 20, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,148——17,184Feb 18, 2026Feb 20, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,026$79.16$239.5K1,276Feb 18, 2026Feb 20, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
48,956——48,956Feb 5, 2026Feb 9, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,154$7.14$15.4K2,154Jan 21, 2026Jan 23, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,749$97.94$367.2K0Jan 21, 2026Jan 23, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,148——19,332Jan 21, 2026Jan 23, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
553$95.49$52.8K3,749Jan 21, 2026Jan 23, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,148$9.08$19.5K4,302Jan 21, 2026Jan 23, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,154——19,397Jan 21, 2026Jan 23, 2026 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,148$9.08$19.5K4,302Dec 17, 2025Dec 19, 2025 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,302$96.47$415.0K0Dec 17, 2025Dec 19, 2025 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,154$7.14$15.4K2,154Dec 17, 2025Dec 19, 2025 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,148——21,480Dec 17, 2025Dec 19, 2025 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,154——21,551Dec 17, 2025Dec 19, 2025 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,148$9.08$19.5K4,302Nov 19, 2025Nov 21, 2025 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
2,154$7.14$15.4K2,154Nov 19, 2025Nov 21, 2025 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,500$85.72$128.6K2,802Nov 19, 2025Nov 21, 2025 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,802$86.51$242.4K0Nov 19, 2025Nov 21, 2025 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,154——23,705Nov 19, 2025Nov 21, 2025 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,148——23,628Nov 19, 2025Nov 21, 2025 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,373——5,373Feb 5, 2025Feb 10, 2025 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
123,559——123,559Feb 5, 2025Feb 10, 2025 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
27,843——27,843Dec 13, 2024Dec 17, 2024 ↗View →
Other insiders · PVLA
Loading peer insiders…
About this filer
CIK 0001912570
ROLE
Chief Operating Officer
PRIMARY
PVLA
COMPANIES
1
ACTIVE SINCE
Dec 2024
MARKETPEEL · /INSIDER/0001912570DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback